Ixodes Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

Ixodes General Information

Description

Developer of pharmaceutical products designed to treat tick-borne diseases. The company's products include therapeutic creams which are used as a preventative treatment for tick-borne borreliosis bacteria, as well as used as protection for Lyme disease, enabling patients to get rid of tick and Lyme borne diseases in a hassle-free manner.

Contact Information

Website
www.ixodes.ch
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Geissacher 10
  • 8126 Zumikon
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Geissacher 10
  • 8126 Zumikon
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ixodes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
2. Early Stage VC 15-Jun-2012 Completed Generating Revenue
1. Early Stage VC 24-Feb-2011 $16.6M $16.6M Completed Generating Revenue
To view Ixodes’s complete valuation and funding history, request access »

Ixodes Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Ixodes’s complete cap table history, request access »

Ixodes Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

Ixodes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100130437-A1 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007
AU-2008280131-A1 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007
AU-2008280131-A8 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007
AU-2008280131-B2 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007
AU-2008280131-B9 Topical antibiotic composition for the prevention of lyme disease Active 25-Jul-2007 A61K9/0014
To view Ixodes’s complete patent history, request access »

Ixodes Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Ixodes FAQs

  • When was Ixodes founded?

    Ixodes was founded in 2007.

  • Where is Ixodes headquartered?

    Ixodes is headquartered in Zumikon, Switzerland.

  • What is the size of Ixodes?

    Ixodes has 2 total employees.

  • What industry is Ixodes in?

    Ixodes’s primary industry is Drug Discovery.

  • Is Ixodes a private or public company?

    Ixodes is a Private company.

  • What is Ixodes’s current revenue?

    The current revenue for Ixodes is .

  • How much funding has Ixodes raised over time?

    Ixodes has raised $18.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process